NKMax Co Ltd banner
N

NKMax Co Ltd
KOSDAQ:182400

Watchlist Manager
NKMax Co Ltd
KOSDAQ:182400
Watchlist
Price: 2 020 KRW 9.54% Market Closed
Market Cap: ₩172.7B

NKMax Co Ltd
Investor Relations

NKMAX Co., Ltd. engages in the development, manufacture, and sale of recombinant proteins and monoclonal antibodies. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-10-23. The firm is involved in the production and sale of recombinant proteins, monoclonal antibodies, NK cell activity test kits, cell therapy products, and in the provision of other related services. The NK cell activity test kits are provided under the name of NK Vue. The firm distributes its products within domestic market and to overseas markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Sangwoo Park
Chairman & CEO
No Bio Available
Yong Hwan Cho
COO & VP
No Bio Available
Dr. Yong Man Kim Ph.D.
Executive Director & Chief Technical Officer
No Bio Available

Contacts

Address
GYEONGGI-DO
Seongnam
1/6F, Healthcare Innovation Park, 172, Dolma-ro, Bundang-gu
Contacts
+823180178114
nkmax.com